publication venue for
- Translocation t(11;17) in de novo myelodysplastic syndrome not associated with acute myeloid or acute promyelocytic leukemia. 2012
- Warfarin-induced skin necrosis in a patient with heparin-induced thrombocytopenia: two diseases or one? 2008
- Evaluation of JAK2 in B and T cell neoplasms: identification of JAK2(V617F) mutation of undetermined significance (JMUS) in the bone marrow of three individuals. 2007
- Hemoglobin sickle-lepore: an unusual case of sickle cell disease. 1997
- The role of radiation therapy in the management of hematopoietic neurologic complications in thalassemia. 1991
- A new family with hereditary choreo-acanthocytosis. 1987
- Extramedullary presentation of blast crisis in chronic myelogenous leukemia. 1985
- ECLIPSE-PV: A Randomized, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Two Dosing Regimens of Ropeginterferon Alfa-2b-Njft in Polycythemia Vera. 2025
- Outcomes of Fedratinib in Routine Treatment of Ruxolitinib-Resistant or -Refractory Patients with Primary and Post-Polycythemia Vera or Essential Thrombocythemia Myelofibrosis: A Nationwide Retrospective Study.. 148. 2024
- Complete Remission with Incomplete Blood Count Recovery Is a Strong Predictor of Nonrelapse Mortality in Acute Myeloid Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation.. 144. 2021
- Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry.. 143. 2019
- Extended Small-Dose Platelet Transfusions in Multitransfused Hemato-Oncological Patients: A Single-Center Experience.. 137. 2017
- Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic Leukemia.. 136. 2016
- Hypogonadism in patients with sickle cell disease: central or peripheral?. 128. 2012
- Evaluation of the incidence of sensorineural hearing loss in beta-thalassemia major patients under regular chelation therapy with desferrioxamine.. 108. 2002
- Biological determinants of long-term survival in chronic myelogenous leukemia patients treated with conventional chemotherapy.. 97. 1997
- Transfer of human adenine deaminase gene into murine hematopoietic stem cells: sequential study of spleen colony-forming units from bone marrow of living mice and the requirement of the microenvironment.. 96. 1996
- Incidence and treatment of tumor lysis syndrome in patients with acute leukemia.. 91. 1994
- Immunophenotypic analysis of lymphocytes and myeloma cells in patients with multiple myeloma.. 83. 1990
- Hypersegmented neutrophils and vitamin B12 deficiency. Hypersegmentation in B12 deficiency.. 81. 1989
- Immunophenotypic demonstration of two natural killer surface markers, H25 and H366, on fresh human leukemic cells.. 82. 1989
- Cell-mediated toxicity of interleukin-2-activated lymphocytes against autologous and allogeneic human myeloma cells.. 80. 1988
- Comparative regimens for the ex vivo chemopurification of B cell lymphoma-contaminated marrow.. 80. 1988
- Ex vivo treatment of myeloma cells by 4-hydroperoxycyclophosphamide and VP-16-213.. 80. 1988
- Acute Febrile Neutrophilic Dermatosis (Sweet Syndrome) in Acute Myeloid Leukemia Patients: A 28-Year Institutional Experience.. 147. 2023
- It's Time to Take Clarithromycin Seriously in Multiple Myeloma.. 135. 2015
- JAK2 and MPL mutations in myeloproliferative neoplasms. 2008
- T cells, graft-versus-host disease and graft-versus-leukemia: innovative approaches for blood and marrow transplantation. 1996